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1. Introduction
After becoming an established technique for the sepa-
ration of enantiomers of chiral compounds (Juza et al.,
2000), the next challenge for the Simulated Mov-
ing Bed (SMB) technology is its application to bio-
separations (Imamoglu, 2002). Examples of products
that are considered for SMB separation are therapeuti-
cal proteins, antibodies, nucleosides and plasmid DNA.
As in the case of chiral applications, it will be necessary
to prove that SMB outperforms column chromatog-
raphy and that the media used as stationary phases
are stable enough. In this context an important issue
is that of the regeneration of the media that is neces-
sary in bio-separations and is called cleaning in place
(CIP). This can be carried out by periodically con-
tacting the column with a concentrated sodium hy-
droxide (1 M in this work) solution with the aim of
removing all species that might have poisoned the
media.
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In this work, we present the application of the SMB
process to one of the purification steps in the down-
stream processing of plasmid DNA (pDNA). There are
a few novel results in this work. First, this is to the
best of our knowledge the first application of SMB to
pDNA purification. The separation principle is size ex-
clusion, thanks to the wide differences in molecular
size between pDNA and the other species in the feed
mixture. Secondly, this is a group separation, where
there is a large number of unspecified species in the
feed all having different retention time in the columns
due to different degrees of pore accessibility and reten-
tion. We extend the SMB design criteria to deal with
this new situation. Finally, we utilize a SMB operation
that has been introduced for three fraction separations,
and is ideally suited for an on-line implementation of
CIP.
2. Interest of pDNA Purification
Prokaryotic cells, e.g. bacteria, have one single chro-
mosome containing its genetic information. This is a
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double stranded DNA molecule called chromosomic
DNA or cDNA, which is circular in most of the cases.
Many bacteria have in addition one or several extra-
chromosomal genetic elements, called plasmids, that
are not essential, but confer an advantage to the cell.
The plasmids have autonomous replication capacity
and every specific plasmid has a characteristic aver-
age number of copies per cell, going from a few in
some cases to several hundreds in others. A plasmid
can be genetically modified in such a way that an in-
teresting gene be inserted into it. A gene is a sequence
of nucleotides (primary structural units of DNA and
RNA) that codifies the necessary information to pro-
duce a certain protein, e.g., one having therapeutical
interest. This possibility is at the basis of the plasmid-
based therapies, where the plasmid is the so-called vec-
tor. It conveys the gene of interest to the cells and tis-
sues of the patient, where its expression produces the
required protein, exactly where it is needed (Ferreira
et al., 2000).
The success of pDNA in gene therapy and for a new
generation of vaccines depends on the development
of safe and competitive production processes (Ferreira
et al., 2000; Levy et al., 2000; Shamlou, 2003; Stadler
et al., 2004). First, in a fermentation reactor the bacte-
rial cells are grown. In order to harvest the plasmid that
is produced in the cells, a lysis is carried out, to destroy
the wall and cellular membrane. Lysis yields a mixture
of cell debris (fragments of wall, membrane and other
solids) that can be separated by centrifugation, thus ob-
taining the clarified lysate from which plasmid is to be
purified. If the lysis is successful, most of the cDNA
is separated with the cell debris during the centrifu-
gation. It is required that the purified plasmid remain
in the supercoiled circular covalently closed form (ccc
pDNA). Even in the case of high copy number pDNA,
its concentration in the clarified lysate does not exceed
3%, whereas the other species are cDNA, RNA, pro-
teins and endotoxins (Stadler et al., 2004). The latter
are liposaccharides (LPS), which are abundant in the
outer cell membrane of most bacteria and are released
in large amounts during lysis. Endotoxins are toxic and
therefore their removal is absolutely necessary.
The separation principle investigated in this work is
the size exclusion mechanism, which is a conventional
way of separating pDNA from RNA in preparative
chromatography (Stadler et al., 2004). Plasmid DNA is
excluded from the pores of the media, whereas RNA,
proteins, salts, and other small molecules are eluted
later. Endotoxins and cDNA are larger than pDNA in
principle, but are fragmented during lysis and sample
preparation and therefore are only partly excluded from
the pores.
3. Experimental
Nine chromatographic columns (10 cm length, 1 cm
internal diameter, V = 7.85 ml) were packed with
the size exclusion media Sepharose 6 Fast Flow from
Amersham Biosciences (90 µm particle size). Eight
columns were used in the SMB, while the ninth
was used for analytical purposes. The packing qual-
ity and column efficiency were assessed through ace-
tone and potassium chloride injections. A modified
¨AKTAexplorer unit (Amersham Biosciences) was used
to run the SMB experiments, as well as the analysis
(Abel et al., 2003). All experiments were performed in
a 100 mM Tris/HCl buffer with 10 mM EDTA and 2
M ammonium sulfate (AS) (Stadler et al., 2004). All
chemicals were purchased from Fluka (Buchs, Switzer-
land). Three different pDNA samples were used, rang-
ing from 5 to 8 kilobases. The first (pDNA sample 1)
was obtained from Strathmann Biotec AG (Dengels-
berg, Germany), whereas the second (pDNA sample 2)
and the third (pDNA sample 3) were prepared in our
labs during two independent lysis of frozen cell ob-
tained from the same fermentation batch. The clear
lysate was concentrated before SMB separation us-
ing an ultrafiltration unit from Amersham Biosciences,
which is equipped with a hollow fibre membrane with
a 300 kDa NMWC (nominal molecular weight cutoff)
operated at a flux of 20 l/(hm2). Samples from SMB
product streams were analyzed after desalting by gel
filtration.
4. Design of the CIP-SMB Separation
The separation of pDNA from RNA is carried out in the
CIP-SMB unit, whose scheme is illustrated in Fig. 1.
It is constituted of five sections (column configura-
tion 1-2-2-2-1), which are labelled 0, 1, 2, 3, and r .
Sections 1 to 3 constitute a standard three section SMB
where the species excluded from the pores are sepa-
rated from those having access to the pores, and are
collected in the raffinate. CIP takes place in section
0, using a proper regeneration solvent, namely a 1 M
NaOH solution. Section r is required to re-equilibrate
the column that has undergone CIP with the solvent
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Figure 1. Scheme of a CIP-SMB unit for the separation of the more retained species A and the less retained species B.
buffer system used for the separation. This is a spe-
cial case of the three fraction SMB operation that has
been recently demonstrated through experiments (Abel
et al., 2003) and simulations (Paredes et al., 2004). A
similar scheme was proposed also in the patent litera-
ture (Voigt et al., 2001).
The SMB operating conditions are conveniently
given in terms of flow rate ratios, m j , that are defined
in each section of the unit as follows (Mazzotti et al.,
1997; Migliorini et al., 1999):
m j =
Q j t∗ − V ε − V Dj
V (1 − ε) (1)
where V and ε are bed volume and void fraction, re-
spectively, and Q j and V Dj are the flow rate and the
extra-column dead volume (per column) in section j ,
respectively (through potassium chloride pulse injec-
Figure 2. (left) Chromatogram of a 500 µL injection of pDNA sample 2 at Q = 0.8 ml/min; the retention times selected to calculate γi in
Eq. (2) are highlighted; injection is performed at 3.2 minutes. (right) Chromatogram illustrating saturation of a column with the CIP solution
(1 M NaOH) and regeneration with the buffer solution (Q = 0.9 ml/min).
tions the following values in ml were obtained: V D0 =
0.015; V D1 = 0.073; V D2 = 0.135; V D3 = 0.068;
V Dr = 0.015).
In order to determine the range of feasible m j values
a number of single column experiments have been car-
ried out, and the two most significant ones are shown in
Fig. 2, namely a pulse chromatogram of the feed mix-
ture and a complete CIP/regeneration cycle. The reten-
tion times of the chromatographic peaks in Fig. 2(left),
as well as the breakthrough times of the pH fronts in
Fig. 2(right), are:
t Ri = V (ε + (1 − ε)γi )/Q (2)
where the parameter γi depends on the fraction of pores
accessible to species i , ε pi , and on retention according to
the equation γi = ε pi + (1−ε pi )Ki , with Ki accounting
for its possible retention (it coincides with the Henry’s
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constant for linear adsorption). We evaluate the exper-
iments in Fig. 2 as follows: by assuming that pDNA
is completely excluded from the pores and elutes with
the first peak, i.e. γpDNA = 0 and ε = 0.32; by ob-
serving that the second peak in Fig. 2(left) is broad
and constituted of a group of species, and by describ-
ing it through a characteristic time for the elution of
the first, big peak, i.e. γRNA = 0.92 in Fig. 2(left),
and a characteristic time for the elution of the tail,
i.e. γn , which is between 1.6 and 2.0 depending on
the batch (the value of γRNA indicates pore accessi-
bility and some interaction with the resin, probably
due to the high ammonium sulfate concentration; γn
should be viewed just as an important parameter for
the design of section 1 of the SMB—see Eq. (4));
by noticing that the times where the pH of the CIP
solution is reached and where regeneration is com-
plete are very similar, and can be characterized by
γr = 1.7.
Using these values, and following the design ap-
proach presented earlier (Paredes et al., 2004), the fol-
lowing conditions for complete separation and proper
regeneration in the CIP-SMB operation of Fig. 1 can
be written:
γr ≤ m0 (3)
γn ≤ m1 (4)
γpDNA ≤ m2 ≤ γRNA (5)
γpDNA ≤ m3 ≤ γRNA (6)
γr ≤ mr (7)
It is worth noting that conditions (3) and (7) apply
only where the same buffer and the same CIP solution
as in the experiment of Fig. 2(right) are used. Moreover,
these do not consider the need for a specified contact
time with the CIP solution that might be a requirement
by drug regulatory authorities and will be considered
in a successive work.
Table 1. Operating conditions and separation performance of the experimental runs; the indication pure raffinate
means that the concentration of the impurity was below the limits of detection.
Run Sample t∗ [min] m0 m1 m2 m3 mr Raff. quality Pr [mg/(h ml)]
A 1 5 2.71 2.94 0.439 0.762 0.651 Pure 0.316
B 2 5 2.71 2.94 0.439 0.762 0.651 Pure 0.316
C 2 5 0.651 2.44 0.271 0.762 −0.005 Pure 0.487
D 3 5 3.12 2.19 0.271 1.01 4.02 Impurities 0.744
5. Experimental Results, Discussion,
and Conclusions
Four SMB experiments were carried out at the con-
ditions reported in Table 1, where also the raffinate
quality and the productivity are reported. The latter pa-
rameter is calculated as the ratio between feed flow rate
and SMB volume, i.e. 8 V, multiplied by the pDNA
concentration in the feed. Since this concentration is
difficult to quantify and depends on the sample, a ref-
erence value of 1 mg/ml has been used in all runs for
comparison. In runs A to C isocratic conditions were
adopted, hence sections 0 and r were used only for test-
ing of the experimental set-up; the values of m0 and mr
in run C are in fact so small in order to save solvent.
On the contrary in run D the CIP-SMB operation was
implemented, by using the CIP solution in section 0
and by carrying out regeneration in section r. Since this
was a proof-of-concept run, m0 and mr values much
larger than the theoretical limit have been adopted. In
all runs the cyclic steady state was reached after two to
three cycles.
It can be readily observed that all runs fulfill the sepa-
ration requirements of Eqs. (4) to (6), and in fact in runs
A to C no pDNA could be detected in the extract, and
no other species but pDNA could be found in the raffi-
nate. This is illustrated with an example in Fig. 3(left)
where the analysis of the raffinate produced during run
C is shown. One can observe the pDNA peak, but no
peak for the non-excluded species. The negative peak
on the right is assumed to be a system peak (solvent
peak) due to the difference in composition between the
analytical mobile phase and the solvent in the injected
pulse. It is worth noting that runs A and B have been
carried under the same conditions but with samples
from different batches.
Run D has been successfully carried out in the CIP-
SMB mode. This has been carefully verified by check-
ing that the pH at the outlet of the column in section
r reached the value corresponding to the mobile phase
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Figure 3. (left) Run C: Chromatogram of a 500 µL injection of the raffinate (Q = 0.8 ml/min). (right) Run D: pH profile at the outlet of the
re-equilibration section during four switch periods at cyclic steady state.
buffer used in sections 1 to 3 of the SMB. That this
is indeed the case is illustrated in Fig. 3(right) where
the pH profile at the outlet of section r is monitored for
a few switch periods. Since the chosen value of mr is
much larger than its lower bound, namely 4.02 instead
of 1.7, actually complete regeneration of the column
is achieved much earlier than necessary, as expected.
In run D m3 is larger than its upper bound in Eq. (6),
thus leading to a larger productivity but also to the
presence of some pollutants in the raffinate, which are
evident in the gel electrophoresis. This is typical of sep-
aration processes, particulary of SMB, where the best
compromise between purity and productivity has to be
found.
These results indicate that the CIP-SMB configura-
tion proposed can indeed be used for the purification
of bio-molecules, particularly plasmid DNA. Further
work will address the potential improvement of perfor-
mance with SMB as compared to column chromatog-
raphy, and the possible use of CIP-SMB in a way that
complies with the regulations of the drug administra-
tion bodies.
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